scholarly article | Q13442814 |
P356 | DOI | 10.1093/HMG/10.3.195 |
P8608 | Fatcat ID | release_ru4a3u7jfbahzfkb5n5u34kw5i |
P3181 | OpenCitations bibliographic resource ID | 2890384 |
P698 | PubMed publication ID | 11159937 |
P5875 | ResearchGate publication ID | 12169681 |
P50 | author | Guy Van Camp | Q37645858 |
P2093 | author name string | R J Smith | |
C C Morton | |||
S Prasad | |||
N G Robertson | |||
S Wayne | |||
N Chen | |||
A F Ryan | |||
K Verhoeven | |||
F DeClau | |||
L Tranebjärg | |||
P433 | issue | 3 | |
P921 | main subject | deafness | Q12133 |
P1104 | number of pages | 6 | |
P304 | page(s) | 195-200 | |
P577 | publication date | 2001-02-01 | |
P1433 | published in | Human Molecular Genetics | Q2720965 |
P1476 | title | Mutations in the transcriptional activator EYA4 cause late-onset deafness at the DFNA10 locus | |
P478 | volume | 10 |
Q24676401 | A 4-bp insertion in the eya-homologous region (eyaHR) of EYA4 causes hearing impairment in a Hungarian family linked to DFNA10 |
Q30371643 | A Large Genome-Wide Association Study of Age-Related Hearing Impairment Using Electronic Health Records |
Q55481612 | A Missense Mutation in POU4F3 Causes Midfrequency Hearing Loss in a Chinese ADNSHL Family. |
Q28115636 | A Novel Locus Harbouring a Functional CD164 Nonsense Mutation Identified in a Large Danish Family with Nonsyndromic Hearing Impairment |
Q41742284 | A comparative study of Eya1 and Eya4 protein function and its implication in branchio-oto-renal syndrome and DFNA10 |
Q37183412 | A molecular analysis of neurogenic placode and cranial sensory ganglion development in the shark, Scyliorhinus canicula. |
Q24670142 | A mutation in CCDC50, a gene encoding an effector of epidermal growth factor-mediated cell signaling, causes progressive hearing loss |
Q34366946 | A new locus for nonsyndromic deafness DFNB49 maps to chromosome 5q12.3-q14.1. |
Q35663740 | A novel EYA4 mutation causing hearing loss in a Chinese DFNA family and genotype-phenotype review of EYA4 in deafness |
Q41158700 | A novel mutation of EYA4 in a large Chinese family with autosomal dominant middle-frequency sensorineural hearing loss by targeted exome sequencing |
Q92049097 | Analysis of EYA3 Phosphorylation by Src Kinase Identifies Residues Involved in Cell Proliferation |
Q36088920 | Associations of genetic variations in EYA4, GRHL2 and DFNA5 with noise-induced hearing loss in Chinese population: a case- control study |
Q30502974 | At the speed of sound: gene discovery in the auditory system |
Q38084832 | Atypical protein phosphatases: emerging players in cellular signaling |
Q36404119 | Can you hear me now? A genetic model of otitis media with effusion |
Q34699453 | Continuing to break the sound barrier: genes in hearing |
Q30310130 | Determination of the embryonic inner ear. |
Q36449110 | Development and evolution of the vestibular sensory apparatus of the mammalian ear. |
Q42073167 | Developmental expression patterns of candidate cofactors for vertebrate six family transcription factors |
Q55052710 | Distinct epigenomic patterns are associated with haploinsufficiency and predict risk genes of developmental disorders. |
Q38056038 | EYA1-SIX1 complex in neurosensory cell fate induction in the mammalian inner ear |
Q53224484 | EYA4 Acts as a New Tumor Suppressor Gene in Colorectal Cancer. |
Q38768208 | Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia |
Q38191727 | Establishing the pre-placodal region and breaking it into placodes with distinct identities |
Q35027888 | Etiology of syndromic and nonsyndromic sensorineural hearing loss |
Q35187716 | Evaluation of the contribution of the EYA4 and GRHL2 genes in Korean patients with autosomal dominant non-syndromic hearing loss |
Q34471407 | Evolution of electrosensory ampullary organs: conservation of Eya4 expression during lateral line development in jawed vertebrates. |
Q30411232 | Exome Sequencing Identifies a Mutation in EYA4 as a Novel Cause of Autosomal Dominant Non-Syndromic Hearing Loss |
Q28585081 | Eya1 regulates the growth of otic epithelium and interacts with Pax2 during the development of all sensory areas in the inner ear |
Q41485484 | Eya1-Six1 interaction is sufficient to induce hair cell fate in the cochlea by activating Atoh1 expression in cooperation with Sox2. |
Q35243673 | Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties |
Q88660937 | Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation |
Q28585781 | Eya4-deficient mice are a model for heritable otitis media |
Q28593158 | Eyes absent represents a class of protein tyrosine phosphatases |
Q34648361 | Eyes absent tyrosine phosphatase activity is not required for Drosophila development or survival |
Q92405522 | Familial Interstitial 6q23.2 Deletion Including Eya4 Associated With Otofaciocervical Syndrome |
Q28749118 | Finding new genes for non-syndromic hearing loss through an in silico prioritization study |
Q38393019 | Gene expression profiles of the cochlea and vestibular endorgans: localization and function of genes causing deafness |
Q40587352 | Genetic variation in EYA4 on the risk of noise-induced hearing loss in Chinese steelworks firm sample |
Q26753842 | Genetics of Nonsyndromic Congenital Hearing Loss |
Q36367641 | Genetics of deafness: recent advances and clinical implications |
Q43074046 | High frequency of T9 and CFTR mutations in children with idiopathic bronchiectasis |
Q36983039 | Histopathology of nonsyndromic autosomal dominant midfrequency sensorineural hearing loss |
Q35202865 | How clinicians add to knowledge of development |
Q38011246 | Human HAD phosphatases: structure, mechanism, and roles in health and disease |
Q35550640 | Human Nonsyndromic Sensorineural Deafness |
Q33346003 | Human hereditary hearing impairment: mouse models can help to solve the puzzle |
Q34426824 | Identification of I411K, a novel missense EYA4 mutation causing autosomal dominant non‑syndromic hearing loss |
Q50352502 | Identification of a novel truncation mutation of EYA4 in moderate degree hearing loss by targeted exome sequencing |
Q34573486 | Identification of a rat model for usher syndrome type 1B by N-ethyl-N-nitrosourea mutagenesis-driven forward genetics |
Q36469493 | Induction and specification of cranial placodes |
Q91817291 | Insights into the pathophysiology of DFNA10 hearing loss associated with novel EYA4 variants |
Q37783809 | Making senses development of vertebrate cranial placodes |
Q35607378 | Molecular conservation and novelties in vertebrate ear development |
Q24537783 | Molecular interaction and synergistic activation of a promoter by Six, Eya, and Dach proteins mediated through CREB binding protein |
Q34398395 | Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss |
Q38384722 | New treatment options for hearing loss. |
Q60307553 | Non-Syndromic Hearing Loss and High-Throughput Strategies to Decipher Its Genetic Heterogeneity |
Q34747004 | Non-syndromic autosomal-dominant deafness |
Q64052291 | Novel EYA4 variant in Slovak family with late onset autosomal dominant hearing loss: a case report |
Q89926715 | Prevalence and clinical features of hearing loss caused by EYA4 variants |
Q38824822 | Research progress in pathogenic genes of hereditary non-syndromic mid-frequency deafness |
Q24292967 | SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes |
Q90589960 | Self-reported hearing loss questions provide a good measure for genetic studies: a polygenic risk score analysis from UK Biobank |
Q58722472 | Sensorineural hearing loss and mild cardiac phenotype caused by an mutation |
Q38169872 | Setting appropriate boundaries: fate, patterning and competence at the neural plate border. |
Q92535164 | Single Cell and Single Nucleus RNA-Seq Reveal Cellular Heterogeneity and Homeostatic Regulatory Networks in Adult Mouse Stria Vascularis |
Q28507467 | Sipl1 and Rbck1 are novel Eya1-binding proteins with a role in craniofacial development |
Q89734622 | Small fish, big prospects: using zebrafish to unravel the mechanisms of hereditary hearing loss |
Q27676610 | Structure-function analyses of the human SIX1–EYA2 complex reveal insights into metastasis and BOR syndrome |
Q36392283 | Targeted massive parallel sequencing: the effective detection of novel causative mutations associated with hearing loss in small families |
Q28482486 | The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone |
Q38027074 | The EYA-SO/SIX complex in development and disease |
Q36597900 | The Eyes Absent proteins in development and disease |
Q38025839 | The peripheral sensory nervous system in the vertebrate head: a gene regulatory perspective |
Q37341015 | The six family of homeobox genes in development and cancer |
Q45168505 | The zebrafish dog-eared mutation disrupts eya1, a gene required for cell survival and differentiation in the inner ear and lateral line |
Q28081644 | Transcriptional regulation of cranial sensory placode development |
Q37170113 | USH1H, a novel locus for type I Usher syndrome, maps to chromosome 15q22-23. |
Q37812277 | Unraveling the genetics of otitis media: from mouse to human and back again |
Q34575519 | Using Drosophila to decipher how mutations associated with human branchio-oto-renal syndrome and optical defects compromise the protein tyrosine phosphatase and transcriptional functions of eyes absent |
Q38115171 | What have we learned from murine models of otitis media? |
Q48179924 | Xeya3 regulates survival and proliferation of neural progenitor cells within the anterior neural plate of Xenopus embryos |
Q50447379 | [A new gene locus for an autosomal-dominant non-syndromic hearing impairment (DFNA 33) is situated on chromosome 13q34-qter]. |
Q33649267 | microRNA-224 regulates Pentraxin 3, a component of the humoral arm of innate immunity, in inner ear inflammation |